Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merrimack announces clinical data from Phase 1 study of MM-302
Merrimack announces clinical data from Phase 1 study of MM-302
Merrimack announces clinical data from Phase 1 study of MM-302
Submitted by
admin
on December 13, 2013 - 10:22am
Source:
The Fly on the Wall
News Tags:
MM-302
Merrimack Pharmaceuticals
HER-2 postive breast cancer
Headline:
Merrimack announces clinical data from Phase 1 study of MM-302
Do Not Allow Advertisers to Use My Personal information
